Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis

J Heart Lung Transplant. 2016 Feb;35(2):253-5. doi: 10.1016/j.healun.2015.10.025. Epub 2015 Oct 30.

Authors

Chesney D Castleberry¹, Farhan Zafar¹, Anne I Dipchand², Leah Edwards³, Clifford Chin¹

Affiliations

¹ Heart Institute, Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio.
² Labatt Family Heart Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
³ International Society for Heart and Lung Transplantation Registry, Addison, Texas.

PMID: 26612055
DOI: 10.1016/j.healun.2015.10.025

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Child
Female
Heart Transplantation*
Humans
Immunosuppressive Agents / therapeutic use*
Male
Propensity Score
Registries
TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

Immunosuppressive Agents
MTOR protein, human
TOR Serine-Threonine Kinases